Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Filings indexed 453 across all filing types
Latest filing 2023-03-30 Major Shareholding Noti…
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Change in substantial holding - Tiga Trading Pty Ltd 4 pages 156.2KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder, filed under section 671B of the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial holder in Little Green Pharma Limited. The document is a regulatory filing notifying the market and company of changes in substantial share ownership, not a financial report, earnings release, or management report. It is not an announcement of a report publication but a formal notification of shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is a full notice, not a brief announcement or certification.
2023-03-30 English
Successful completion of $5 million placement 3 pages 272.6KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 24 March 2023 regarding the successful completion of a $5 million placement by Little Green Pharma Ltd. It details the placement terms, use of funds, and timetable for settlement and trading of new shares. The content focuses on fundraising activities, including share issuance and capital structure changes. There is no indication that this is a full financial report, earnings release, or management discussion. The document is not a report publication announcement but a direct announcement of a capital raising event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-03-23 English
Proposed issue of securities - LGP 5 pages 27.9KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from LITTLE GREEN PHARMA LTD regarding a proposed issue of securities, specifically a placement of ordinary fully paid shares. It details the number of securities to be issued, the issue price, the proposed issue date, and compliance with ASX Listing Rules. The content focuses on the capital raising activity and the terms of the securities issuance. There are no financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a regulatory certification or voting result announcement. The document fits the category of Capital/Financing Update as it provides information on a new fundraising activity through a securities placement.
2023-03-23 English
Proposed issue of securities - LGP 5 pages 27.6KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from LITTLE GREEN PHARMA LTD regarding a proposed issue of securities, specifically a placement of 277,777 ordinary fully paid shares. It includes details such as the proposed issue date, approval conditions, issue price, and compliance with ASX listing rules. The content focuses on the company's capital raising activity and the issuance of new shares. There are no financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a report publication announcement or certification. The document clearly fits the category of Capital/Financing Update, as it provides an update on the company's fundraising and capital structure changes through a securities placement.
2023-03-23 English
Reset Mind Sciences and HIF enter Strategic Alliance 3 pages 358.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 22 March 2023, describing a strategic alliance between Reset Mind Sciences and Health Insurance Fund of Australia to establish a mental health treatment facility offering psychedelic assisted psychotherapy. It includes details of the agreement, funding, exclusivity period, and statements from CEOs. There are no financial statements, quarterly or annual results, or regulatory filings such as audit reports or governance documents. The content focuses on a business partnership and strategic development rather than financial performance or regulatory compliance. The document length is 8021 characters, which is substantial but the content is clearly an announcement of a strategic alliance rather than a financial report or regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP), as it relates to a strategic business alliance and funding contribution for a new facility.
2023-03-21 English
Trading Halt 2 pages 204.0KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Little Green Pharma Ltd regarding a trading halt requested pending a forthcoming announcement about a proposed capital raise. It references ASX Listing Rule 17.1 and states the halt is to manage continuous disclosure obligations until the announcement is made. The document does not contain financial statements or detailed financial data but is an announcement about a trading halt related to capital raising activities. This fits the category of Capital/Financing Update (CAP) as it concerns financing activities and capital structure changes, not the actual capital raise announcement or report itself.
2023-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.